1 of 1
Story summary
- Justices Vikram Nath and Sandeep Mehta called steep medicine mark-ups ‘carnage’ and urged a uniform 16% margin.
- They cited a cancer drug priced at INR2,700 to retailers but INR27,000 to consumers.
- Solicitor General Tushar Mehta said private hospitals, not pharma firms, profit from the markup.
- Petitions by Kishan Chand Jain and Sanjay Kulshrestha seek stricter price controls, with the case adjourned to October 12, 2026.
